Cardiometabolic Health Congress - CMHC
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Cardiometabolic Health Congress - CMHC — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
Cardiometabolic Health Congress (CMHC) — Event Description
The 21st Annual Cardiometabolic Health Congress (CMHC) is an international, clinician-focused educational event centered on cardiometabolic care—the prevention, understanding, and management of interconnected risk factors and diseases affecting whole-patient health. CMHC is designed to help healthcare providers translate evolving research into actionable, evidence-based strategies that improve outcomes for patients with complex cardiometabolic conditions.
Dates: October 15–17, 2026, with a pre-conference on October 14, 2026.
Venue: Boston Park Plaza
City & Country: Boston, United States
Purpose and Event Positioning
CMHC is more than a traditional conference: it is a platform where healthcare providers come together to strengthen knowledge, refresh clinical toolkits, and engage with cutting-edge advancements in cardiometabolic health. Across multiple tracks, the program emphasizes real-world clinical decision-making, practical case-based learning, and global collaboration among clinicians, thought leaders, and innovators.
The congress is also positioned as continuing education for healthcare professionals, with programming that supports clinicians who need to stay current on rapidly evolving therapies, diagnostic approaches, and management strategies. The event highlights both breakthrough content and hands-on learning, including interactive workshops and practical session formats focused on addressing challenging patient scenarios.
Featured Learning Tracks and Clinical Themes
CMHC is structured around distinct clinical education areas, giving attendees a clear pathway to explore the latest clinical updates and management strategies within their specialty interests. Featured tracks include:
-
CardioRenal / Hypertension
Examples of featured topics include bridging cardio-kidney-metabolic care for chronic disease management, and exploring emerging therapies and clinical insights for resistant and uncontrolled hypertension. -
Obesity & Lifestyle
Education themes include diet quality and its cardiovascular, metabolic, and broader health benefits, as well as sleep disturbance impacts on cardiometabolic health. -
Diabetes
Sessions address transforming diabetes care through digital solutions and CGM approaches, and managing diabetes in elderly populations with attention to unique glucose tolerance challenges. -
Dyslipidemia / Atherosclerosis / Thrombosis
Program highlights include rethinking primary prevention strategies for ASCVD and how modern imaging, calcium scoring, CTA, and AI may influence ASCVD management.
Pre-Conference Program (October 14, 2026)
The congress includes a women’s health pre-conference focused on cardiometabolic health and wellness. This pre-conference is presented as a masterclass and includes its own educational structure and credited learning format.
Women’s Cardiometabolic Health and Wellness Masterclass
October 14, 2026
Why Attendees Come to CMHC
CMHC’s value proposition is built around five consistent pillars that reflect what healthcare professionals need from a high-quality scientific and clinical education meeting:
- A Legacy of Excellence: CMHC emphasizes a long-standing commitment to cardiometabolic education, designed to help healthcare providers remain ahead in a rapidly evolving field.
- Breakthrough Content: Attendees gain access to the latest clinical advancements, research updates, and innovative therapies shaping the future of cardiometabolic care.
- Hands-On Learning: The program incorporates interactive workshops, real-world case discussions, and practical sessions aimed at helping clinicians address difficult patient-care challenges.
- Global Collaboration: CMHC brings together a diverse community of healthcare professionals, thought leaders, and innovators to drive cardiometabolic health improvements worldwide.
- Transformative Impact: The congress is built to support immediate clinical application through actionable insights and a refreshed clinical toolkit for complex patients.
Audience and Participation Overview
CMHC is designed for participants who are directly involved in cardiometabolic care and who benefit from continual clinical education and professional learning. The congress is positioned as a gathering point for healthcare providers from around the globe, and it supports a broader ecosystem by also serving clinicians, students, and others who seek up-to-date resources in cardiometabolic health.
While CMHC is fundamentally an education and continuing-professional-development event, it also functions as a place for knowledge exchange across the cardiometabolic care landscape—encouraging attendees to connect, learn, and lead in the management and prevention of interconnected conditions involving cardiovascular, renal, metabolic, and related disease processes.
Agenda Preview: Examples of Session Concepts
The congress agenda highlights representative sessions that reflect the program’s focus areas:
Session I: CardioRenal / Hypertension
- The CKM Axis: Bridging Cardio-Kidney-Metabolic Care for Chronic Disease Management
- Advancements in the Management of Resistant and Uncontrolled Hypertension: Emerging Therapies and Clinical Insights
Session II: Obesity & Lifestyle
- The Science of Diet Quality: Transforming Cardiovascular, Metabolic, and Cancer Benefits
- The Plethora of Sleep Disturbances and Their Impact on Cardiometabolic Health
Session III: Diabetes
- Transforming Diabetes Care: Leveraging Digital Solutions and CGM for Better Outcomes
- Diabetes Management in the Elderly: Navigating Glucose Tolerance and Unique Challenges
Session IV: Dyslipidemia / Atherosclerosis / Thrombosis
- Too Little, Too Late? Rethinking Primary Prevention Strategies for ASCVD
- ASCVD Management Redefined: The Impact of Imaging, Calcium Scoring, CTA, and AI
Expected Outcomes for Attendees
By the end of the congress, CMHC aims for attendees to leave with practical clinical guidance and a reinforced, evidence-based approach for complex cardiometabolic cases. The educational experience is intended to support improved patient outcomes by helping clinicians translate new evidence and therapies into everyday care decisions.
Official Event Notes
The conference agenda is subject to change. CMHC notes that while it aims to provide the most accurate and up-to-date schedule, adjustments may occur as needed.
For the latest updates and full details, CMHC provides registration and agenda access through its official event pages.
Data sheet
| Event Name | 21st Annual Cardiometabolic Health Congress (CMHC) |
| Event Date | October 15–17, 2026 (Pre-conference: October 14, 2026) |
| Event Status | Upcoming |
| Venue | Boston Park Plaza Hotel |
| City | Boston |
| State / Region | Massachusetts (MA) |
| Country | United States |
| Organizer | Cardiometabolic Health Congress (CMHC) |
| Official Event Website | cardiometabolichealth.org |
| Event Type | Medical education congress / clinical conference / continuing education event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Wellness, Health & Fitness; Science & Research; IT & Technology |
| Audience Reach | Global clinical education audience; strongest attendance expected from the U.S. and North America |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | High for dates, venue, and topic focus; low for attendance totals because no public official figure was provided in the source text. |
| Main Purpose of Event | To educate healthcare providers on cardiometabolic disease, share clinical advances, and support actionable care strategies for cardiovascular, renal, metabolic, diabetes, obesity, lipid, and hypertension management. |
The Cardiometabolic Health Congress (CMHC) is a specialized clinical education event focused on the prevention, diagnosis, and treatment of cardiometabolic disease. Its agenda spans cardiovascular disease, chronic kidney disease, diabetes management, obesity, dyslipidemia, hypertension, lifestyle medicine, and care delivery implementation, with sessions designed to translate research into practical clinical action.
This event matters because cardiometabolic conditions represent a major and growing global healthcare burden, making CMHC relevant to clinicians, researchers, care delivery leaders, and healthcare organizations looking for evidence-based education and treatment innovation. The meeting has strong value for medical education buyers, pharmaceutical and medtech suppliers, digital health providers, and organizations supporting clinical decision-making and patient outcomes.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Clinicians and physicians | Hospitals, health systems, academic medical centers, specialty practices | Treatment protocol influence, prescribing influence, clinical adoption | High-value audience for therapies, diagnostics, clinical tools, and education services |
| Medical directors / care pathway leaders | Health systems, population health organizations, value-based care groups | Guideline alignment, pathway design, utilization decisions | Relevant for care management, digital health, diagnostics, and outcomes solutions |
| Endocrinology and diabetes teams | Diabetes centers, endocrinology groups, integrated care organizations | Therapy selection, device adoption, patient management | Strong fit for diabetes technologies, CGM, insulin support, and patient engagement solutions |
| Cardiology leaders | Cardiology practices, hospitals, specialty networks | Clinical decision-making, adoption of prevention and intervention approaches | Relevant for cardiovascular drugs, imaging, diagnostics, and risk stratification tools |
| Nephrology / cardiorenal care teams | Renal clinics, hospitals, integrated cardiorenal programs | Care pathway influence for CKD-related therapy and monitoring | Relevant for renal-metabolic therapies, lab tools, and monitoring systems |
| Hospital and health-system leadership | Hospitals, accountable care organizations, IDNs | Program investment, platform selection, clinical education budget influence | Useful for enterprise sales, care transformation, and population health solutions |
| Researchers and academic faculty | Universities, research hospitals, institutes | Evidence generation, publication influence, clinical trial design | Relevant for research tools, trial services, and educational partnerships |
| Pharma and life sciences medical affairs | Pharmaceutical companies, biotech firms, device makers | Scientific exchange, KOL engagement, evidence dissemination | High relevance for sponsorship, HCP education, and medical communications |
| Digital health and technology buyers | Healthcare technology firms, telehealth providers, remote monitoring vendors | Solution evaluation, partnerships, workflow integration | Relevant for AI, analytics, patient engagement, and CGM-adjacent software |
| Medical education / CME leaders | Professional education groups, associations, universities | Program selection, content partnerships, accreditation decisions | Relevant for education providers, content sponsors, and association partnerships |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Boston | Local clinicians, academic faculty, hospital teams, life sciences professionals | High | Boston is a major healthcare, biotech, and academic medicine hub. |
| Host state / region: Massachusetts / Northeast | Regional health systems, university hospitals, specialty clinicians | High | Strong concentration of medical decision-makers and research institutions. |
| Nearby business hubs | New York, Philadelphia, Washington, DC, New Jersey, Connecticut | Medium-High | Accessible for clinical, pharma, and health technology attendees. |
| National reach | U.S. clinicians, researchers, payer-facing leaders, medtech and pharma teams | High | Official event copy references a national and global healthcare audience. |
| International reach | Global clinicians, educators, and researchers | Medium | Official site states the event will unite healthcare providers from around the globe. |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official event copy states that CMHC unites healthcare providers “from around the globe,” while the strongest buyer density is likely in the U.S. and Northeast corridor. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Mass General Brigham | Health system / care delivery organization | Large cardiometabolic care footprint; likely attendee and buyer for clinical education and digital care tools | massgeneralbrigham.org | CMO, Medical Director, Endocrinology Director, Cardiology Director, Population Health Leader | Strong Market Fit, Attendance Not Confirmed |
| Brigham and Women’s Hospital | Academic medical center | Strong clinical and research relevance in cardiology, endocrinology, and internal medicine | brighamandwomens.org | Department Chair, Clinical Director, Faculty Lead, Research Director | Strong Market Fit, Attendance Not Confirmed |
| Beth Israel Deaconess Medical Center | Academic medical center | Relevant for cardiometabolic disease management, clinical education, and research participation | bidmc.org | Medical Director, Endocrinology Lead, Cardiology Lead, Research Faculty | Strong Market Fit, Attendance Not Confirmed |
| Boston Medical Center | Safety-net hospital / health system | High need for cardiometabolic care, chronic disease management, and health equity programs | bmc.org | Chief Medical Officer, Diabetes Program Director, Community Health Leader | Strong Market Fit, Attendance Not Confirmed |
| Dana-Farber Cancer Institute | Specialty medical center / research institute | Relevant for cardio-oncology, metabolic health, and clinical research education | dana-farber.org | Clinical Research Director, Physician Leader, Program Director | Strong Market Fit, Attendance Not Confirmed |
| AstraZeneca | Pharmaceutical company | Strong cardiometabolic portfolio relevance and medical affairs / HCP education use case | astrazeneca.com | Medical Affairs Director, Brand Lead, Market Access Director, KOL Engagement Lead | Strong Market Fit, Attendance Not Confirmed |
| Novo Nordisk | Pharmaceutical company | Highly relevant to diabetes, obesity, and metabolic health education audiences | novonordisk.com | Medical Director, Scientific Affairs Lead, Field Medical Director | Strong Market Fit, Attendance Not Confirmed |
| Amgen | Biopharmaceutical company | Relevant for lipid management, atherosclerosis, and medical education engagement | amgen.com | Medical Science Liaison Director, Cardiovascular Marketing Lead, Medical Affairs | Strong Market Fit, Attendance Not Confirmed |
| Abbott | Medical device / diagnostics company | Relevant for glucose monitoring, diagnostics, and clinical workflow solutions | abbott.com | Product Manager, Clinical Affairs Director, Commercial Lead, Market Access | Strong Market Fit, Attendance Not Confirmed |
| Dexcom | Medical device / digital health company | CGM-centered solutions align strongly with diabetes management sessions | dexcom.com | VP Sales, Clinical Partnerships, Medical Affairs, Product Marketing | Strong Market Fit, Attendance Not Confirmed |
| UnitedHealthcare | Health insurer / payer | Relevant for chronic disease management, outcomes, and care pathway adoption | uhc.com | Medical Director, Clinical Strategy Lead, Pharmacy Director | Strong Market Fit, Attendance Not Confirmed |
| CVS Health | Health services / pharmacy / payer | Large chronic care and pharmacy footprint with strong cardiometabolic relevance | cvshealth.com | Clinical Program Lead, Pharmacy Director, Health Services Strategy | Strong Market Fit, Attendance Not Confirmed |
| Centers for Disease Control and Prevention (CDC) | Government / public health | Public health leadership in diabetes, obesity, cardiovascular risk, and prevention | cdc.gov | Program Officer, Division Director, Public Health Advisor | Strong Market Fit, Attendance Not Confirmed |
| American Diabetes Association | Association / nonprofit | Highly aligned association stakeholder for education, advocacy, and clinical content | diabetes.org | Education Director, Partnerships Director, Scientific Programs Lead | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer | Clinical Leadership | Executive | Owns clinical standards and enterprise adoption of cardiometabolic strategies. |
| 2 | Medical Director | Clinical / Program | Director+ | Influences therapy, pathway, and vendor decisions. |
| 3 | Endocrinology Director | Specialty Care | Director+ | High fit for diabetes, obesity, and metabolic health solutions. |
| 4 | Cardiology Director | Specialty Care | Director+ | Key stakeholder for cardiovascular and preventive care offerings. |
| 5 | Research Director / Faculty Lead | Research / Academic Medicine | Director / Professor | Important for evidence generation, KOL engagement, and trial-related outreach. |
| 6 | Clinical Operations Director | Operations | Director+ | Implements care delivery and workflow changes. |
| 7 | Population Health Director | Population Health / Value-Based Care | Director+ | Strong need for risk reduction and chronic disease management tools. |
| 8 | Pharmacy Director | Pharmacy | Director+ | Relevant for formulary, utilization, and therapy access decisions. |
| 9 | Medical Science Liaison | Medical Affairs | Mid-Senior | Important for scientific exchange and KOL mapping. |
| 10 | Product Manager / Clinical Product Manager | Product / Digital Health | Manager+ | Useful for solution fit, workflow, and feature feedback. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core attendee base is clinical and care delivery organizations. | Clinicians, hospital leadership, care pathway buyers |
| 2 | Pharmaceuticals | Strong relevance to cardiometabolic therapies and medical affairs. | Medical affairs, brand, market access |
| 3 | Medical Devices | Relevant for diagnostics, monitoring, CGM, and treatment support tools. | Product and clinical affairs teams |
| 4 | Biotechnology | Innovation and research discussions are highly relevant. | Research, partnerships, and scientific leadership |
| 5 | Medical Practice | Specialty and multi-specialty practices are strong attendee sources. | Practice owners, physicians, administrators |
| 6 | Research | Scientific content, clinical outcomes, and study data are central themes. | Investigators, study leads, academic partners |
| 7 | Biotechnology | Clinical innovation and translational science are common fit areas. | KOL engagement and pipeline education |
| 8 | Information Technology & Services | Digital health, analytics, and care coordination tools may be relevant. | Digital transformation and workflow buyers |
| 9 | Biotechnology | Useful for translational collaboration and evidence generation. | Scientific and medical leadership |
| 10 | Health, Wellness & Fitness | Lifestyle management and prevention are explicit agenda themes. | Wellness programs, prevention services |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Confirmed unavailable | Official event content provided no attendance figure | Use caution when sizing list volumes |
| Exhibitor count | Not publicly confirmed in source text | Unconfirmed | Official website mentions an exhibit option but not count | Potential B2B exhibitor targeting exists, but quantity not stated |
| Buyer / attendee count | Not publicly confirmed | Unconfirmed | No official figure in provided source text | Attendance figure not publicly confirmed by the organizer. |
| Speaker count | Partial speaker names listed | Confirmed partial | Official event page speaker section | Only a partial list was visible in the provided content |
| Historical attendance | Not provided in supplied official text | Unavailable | Official content provided | Prior-year attendance should be checked on archived brochures or post-event recaps if needed |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Cardiometabolic care | Better outcomes across overlapping chronic diseases | Clinical education and evidence-led solution demos | Therapeutics, care pathways, adherence tools |
| Diabetes management | Glycemic control, patient monitoring, workflow support | Hands-on product education and outcomes messaging | CGM, insulin support, software |
| Obesity and lifestyle | Behavioral support and treatment pathways | Engage with lifestyle medicine and patient support messaging | Behavioral health, wellness, coaching |
| Cardiorenal / hypertension | Risk reduction and disease progression management | Target specialty clinicians and guideline adopters | Clinical therapies, diagnostics, monitoring |
| Dyslipidemia / atherosclerosis | ASCVD prevention and management | Scientific content and protocol-alignment outreach | Lipid-lowering therapies, imaging, diagnostics |
| AI / digital solutions | Decision support and more efficient care delivery | Position data-driven care tools and workflow automation | AI analytics, software, remote monitoring |
| Medical education / CME | High-quality accredited content | Sponsor education tracks and faculty relationships | CME programs, association partnerships |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | Direct concentration of healthcare decision-makers and clinical influencers. |
| Decision-maker availability | High | Medical directors, faculty leaders, and clinical heads are likely present. |
| Data collection potential | Medium | Strong title-based profiling potential, but attendee list is not publicly confirmed. |
| Apollo targeting potential | Very High | Well-defined industries, titles, and departments for healthcare, pharma, and device targeting. |
| Geographic targeting potential | High | Boston and Northeast healthcare clusters can be targeted effectively. |
| Best outreach approach | High | Use clinical-value messaging, evidence-based positioning, and specialty-specific personalization. |
| Overall lead quality | Very High | Strong event for healthcare lead generation, especially in clinical, pharma, and medtech segments. |
| Best use case | Lead generation / account targeting / sponsorship prospecting | Suitable for attendee list sales, buyer profiling, and healthcare outreach. |
| Limitations / risks | Medium | Current-year attendee and exhibitor lists were not fully visible in the provided source text. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Pharmaceuticals; Medical Devices; Biotechnology; Medical Practice; Research; Health, Wellness & Fitness | Align to the most relevant buyer pool |
| Departments | Clinical, Medical Affairs, Research, Product, Operations, Population Health, Pharmacy, Partnerships | Reach both scientific and commercial decision-makers |
| Seniority | Manager, Director, VP, C-level, Professor | Prioritize decision-makers and program owners |
| Job titles | CMO, Medical Director, Clinical Director, Endocrinology Director, Cardiology Director, Medical Affairs Director, MSL, Research Director, Population Health Director, Pharmacy Director | Target the highest-probability buyers and influencers |
| Geography | United States; Northeast; Massachusetts; Boston metro; New York; New Jersey; Pennsylvania; Connecticut | Capture host-market and nearby regional demand |
| Employee size | 51–200; 201–500; 501–1000; 1001–5000; 5000+ | Cover provider organizations, pharma, and enterprise healthcare accounts |
| Keywords | cardiometabolic, diabetes, obesity, cardiology, endocrinology, hypertension, lipid, atherosclerosis, CKD, CGM, population health | Refine by disease area and event theme |
| Company type | Hospitals, health systems, academic medical centers, pharma, medtech, digital health, associations | Target organizations most likely to attend or sponsor |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Cardiometabolic Health Congress official event page | Official organizer source | Event name, date range, pre-conference date, venue, city, educational focus, agenda themes, and global audience positioning | High |
| Cardiometabolic Health Congress homepage | Official organizer website | CMHC mission, cardiometabolic subject coverage, and audience description | High |
| Boston Park Plaza Hotel | Venue website | Venue identification and location context | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Cardiometabolic Health Congress - CMHC — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.